2011
DOI: 10.4062/biomolther.2011.19.3.342
|View full text |Cite
|
Sign up to set email alerts
|

Anticonvulsant Effect of Artemisia capillaris Herba in Mice

Abstract: In the present study, the anticonvulsant effects of Artemisia capillaris Herba (AC) and its major constituent, esculetin (ECT), were tested and the mechanism studied. Locomotion, Myorelaxation, motor coordination and electroshock seizure experiment were conducted in mice. To identify the anticonvulsant mechanism effect of this drug, chemical-induced seizure in mice and the ionic movement in neuroblastoma cells were also observed. The ethanol extract of AC was orally administered to mice 30 min. prior to testin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0
2

Year Published

2013
2013
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(10 citation statements)
references
References 23 publications
0
8
0
2
Order By: Relevance
“…Today, there are still about 30–40% of all patients with epilepsy affected by intolerable toxicity, numerous adverse effects (such as sedation and myorelaxation), and seizure resistance to the current AEDs, which motivate researchers to develop novel approaches to treat epilepsy. Because some medicinal compounds reviewed herein, such as esculetin and wogonin, significantly decreased seizure response but did not cause sedative and myorelaxant effects, it is evident that medicinal plants have the potential to be a rich source for discovering safer and more effective antiepileptic reagents. Although there are insufficient data to support the clinical efficacy of these herbal components in patients with epilepsy—only some phytocannabinoids such as CBD and ∆ 9 ‐THC have individual case studies or have undergone a number of small‐scale human trials—the in vitro and in vivo experimental data reviewed herein could supply the basic science evidence for research and development of novel AEDs from medicinal plants.…”
Section: Discussionmentioning
confidence: 97%
See 1 more Smart Citation
“…Today, there are still about 30–40% of all patients with epilepsy affected by intolerable toxicity, numerous adverse effects (such as sedation and myorelaxation), and seizure resistance to the current AEDs, which motivate researchers to develop novel approaches to treat epilepsy. Because some medicinal compounds reviewed herein, such as esculetin and wogonin, significantly decreased seizure response but did not cause sedative and myorelaxant effects, it is evident that medicinal plants have the potential to be a rich source for discovering safer and more effective antiepileptic reagents. Although there are insufficient data to support the clinical efficacy of these herbal components in patients with epilepsy—only some phytocannabinoids such as CBD and ∆ 9 ‐THC have individual case studies or have undergone a number of small‐scale human trials—the in vitro and in vivo experimental data reviewed herein could supply the basic science evidence for research and development of novel AEDs from medicinal plants.…”
Section: Discussionmentioning
confidence: 97%
“…Coumarins are a group of plant‐derived polyphenolic compounds and are made of fused benzene and α‐pyrone rings, many of which possess a wide range of pharmacologic and biochemical applications. Esculetin (6,7‐dihydroxy‐coumarin) could significantly decrease seizure response induced by electroshock, whereas it did not cause a sedative and myorelaxation effect, and it exerted anticonvulsant effect probably through the GABAergic neuron . Luszczki et al.…”
Section: Medicinal Compounds With Antiepileptic/anticonvulsant Activimentioning
confidence: 99%
“…[7][8][9] Herbal products are preferred alternatives because they usually have fewer side effects than currently available anticonvulsants. For these reasons, our team is searching for herbal products that have anticonvulsive activities with fewer side effects.…”
mentioning
confidence: 99%
“…[13] The ethanol extract of AC (50–400 mg/kg) was orally administered to mice 30 min prior to testing and ECT (1–5 mg/kg) was intraperitoneally injected. Locomotor activities and activities on the rota-rod did not change in treated group, suggesting no sedative and myorelaxation effect.…”
Section: Anticonvulsionmentioning
confidence: 99%